Infection with human herpesvirus type 8 and human T-cell leukaemia virus type 1 among individuals participating in a case-control study in Havana City, Cuba

Br J Cancer. 2002 Nov 18;87(11):1253-6. doi: 10.1038/sj.bjc.6600613.

Abstract

Infection with human herpesvirus type 8 and with human T-cell leukaemia virus type-1 shows strong geographic variations. We conducted this study to assess prevalence and risk factors for human herpesvirus type 8 infection in Havana City, Cuba. Information and residual serum samples already collected for a hospital based case-control study were used. A total of 379 individuals (267 males and 112 females; median age=63 years) were evaluated. Antibodies to the lytic antigen of human herpesvirus type 8 were detected by using an immunofluorescence assay, while human T-cell leukaemia virus type-1 serology was performed by means of an ELISA test (alpha Biotech). Overall, 64 subjects (16.9%, 95% confidence interval: 13.1-20.0) were positive for human herpesvirus type 8 antibodies. Human herpesvirus type 8 seroprevalence significantly increased with age (odds ratio=1.9 for >/=65 vs <55 years), and was twice as frequent in blacks than in whites. No association emerged with gender, socio-economic indicators, family size, history of sexually transmitted disease, sexual behaviour. Overall, 16 persons had anti-human T-cell leukaemia virus type-1 antibodies (4.2%, 95% confidence interval: 2.2-6.4). No relationship emerged between human T-cell leukaemia virus type-1 and human herpesvirus type 8 serostatus. The study findings indicate that human herpesvirus type 8 infection is relatively common in Havana City, Cuba, suggesting that Cuba may represent an intermediate endemical area. Sexual transmission does not seem to play a major role in the spread human herpesvirus type 8 infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Antibodies, Viral / analysis
  • Case-Control Studies
  • Cuba / epidemiology
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • HTLV-I Infections / epidemiology*
  • HTLV-I Infections / etiology
  • Herpesviridae Infections / epidemiology*
  • Herpesviridae Infections / etiology
  • Herpesvirus 8, Human / immunology
  • Herpesvirus 8, Human / pathogenicity*
  • Human T-lymphotropic virus 1 / immunology
  • Human T-lymphotropic virus 1 / pathogenicity*
  • Humans
  • Male
  • Middle Aged
  • Odds Ratio
  • Prevalence
  • Risk Factors
  • Sarcoma, Kaposi / epidemiology
  • Sarcoma, Kaposi / etiology
  • Sarcoma, Kaposi / virology*
  • Urban Population

Substances

  • Antibodies, Viral